(Q50569364)

English

The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation.

scientific article published on 6 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Cytomegalovirus

0 references

immunosuppression

1 reference

based on heuristic

inferred from title

liver transplantation

1 reference

based on heuristic

inferred from title

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

author name string

Liu Sheng

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Shi Jun

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Li Jianfeng

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Gao Lianghui

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

publication date

6 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

29

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

555-559

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12552

21 January 2018

Identifiers

10.1111/CTR.12552

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25851741

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50569364&oldid=1629774315"